Tadalafil

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 27241-113
  • Package NDC 27241-113-03
  • Package NDC 27241-113-05
  • Application number ANDA209654
  • SPL ID 4e9e209a-9f87-41cb-a7ac-a1fbf5412995
  • SPL set ID 7e4cdac1-42cc-4038-a86b-4890962ed806
  • UNII 742SXX0ICT
  • RxCUI 402019
  • RxCUI 403957
  • RxCUI 484814
  • RxCUI 757707

What the source publishes

Labeler
Ajanta Pharma USA Inc.
Active ingredients
Tadalafil
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:27241-113_4e9e209a-9f87-41cb-a7ac-a1fbf5412995
{
  "name": "Tadalafil",
  "splId": "4e9e209a-9f87-41cb-a7ac-a1fbf5412995",
  "labels": [
    {
      "setId": "7e4cdac1-42cc-4038-a86b-4890962ed806",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7e4cdac1-42cc-4038-a86b-4890962ed806",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7e4cdac1-42cc-4038-a86b-4890962ed806"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Ajanta Pharma USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (27241-113-03)",
      "package_ndc": "27241-113-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190326"
    },
    {
      "sample": false,
      "description": "500 TABLET in 1 BOTTLE (27241-113-05)",
      "package_ndc": "27241-113-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200617"
    }
  ],
  "productId": "27241-113_4e9e209a-9f87-41cb-a7ac-a1fbf5412995",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "27241-113",
  "deaSchedule": null,
  "genericName": "Tadalafil",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TADALAFIL",
      "strength": "10 mg/1"
    }
  ],
  "applicationNumber": "ANDA209654",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190326",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175599",
      "N0000020026"
    ],
    "upc": [
      "0327241112034",
      "0327241111037",
      "0327241113031",
      "0327241114038"
    ],
    "unii": [
      "742SXX0ICT"
    ],
    "rxcui": [
      "402019",
      "403957",
      "484814",
      "757707"
    ],
    "spl_set_id": [
      "7e4cdac1-42cc-4038-a86b-4890962ed806"
    ],
    "pharm_class_epc": [
      "Phosphodiesterase 5 Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Phosphodiesterase 5 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Ajanta Pharma USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:27241-113_4e9e209a-9f87-41cb-a7ac-a1fbf5412995"